scholarly journals Supporting people with type 2 diabetes in effective use of their medicine through mobile health technology integrated with clinical care to reduce cardiovascular risk (SuMMiT-D): a protocol for an effectiveness and cost-effectiveness randomised control trial (Preprint)

10.2196/32918 ◽  
2021 ◽  
Author(s):  
Andrew Farmer ◽  
Louise Jones ◽  
Nikki Newhouse ◽  
Cassandra Kenning ◽  
Nicola Williams ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Cardiovascular Risk ◽  
Cost Effectiveness ◽  
Mobile Health ◽  
Clinical Care ◽  
Health Technology ◽  
Randomised Control Trial ◽  
Mobile Health Technology ◽  
Effective Use

scholarly journals Mobile health technology in the prevention and management of Type 2 diabetes

2017 ◽  
Vol 21 (2) ◽  
pp. 334 ◽  
Author(s):  
Viswanathan Mohan ◽  
Shruti Muralidharan ◽  
Harish Ranjani ◽  
RanjitMohan Anjana ◽  
Steven Allender
Keyword(s):  
Type 2 Diabetes ◽  
Mobile Health ◽  
Health Technology ◽  
Mobile Health Technology

scholarly journals Mobile Health Technology (mDiab) for the Prevention of Type 2 Diabetes: Protocol for a Randomized Controlled Trial

2017 ◽  
Vol 6 (12) ◽  
pp. e242 ◽  
Author(s):  
Shruti Muralidharan ◽  
Viswanathan Mohan ◽  
Ranjit Mohan Anjana ◽  
Sidhant Jena ◽  
Nikhil Tandon ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Randomized Controlled Trial ◽  
Mobile Health ◽  
Controlled Trial ◽  
Health Technology ◽  
Mobile Health Technology ◽  
Randomized Controlled

scholarly journals Cost-effectiveness and budget impact of liraglutide in type 2 diabetes patients with elevated cardiovascular risk: a US-managed care perspective

2018 ◽  
Vol Volume 10 ◽  
pp. 791-803 ◽  
Author(s):  
Dhvani Shah ◽  
Nancy A Risebrough ◽  
Johnna Perdrizet ◽  
Neeraj N Iyer ◽  
Cory Gamble ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Cardiovascular Risk ◽  
Cost Effectiveness ◽  
Managed Care ◽  
Budget Impact ◽  
Diabetes Patients

Cost-Effectiveness of Empagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus at Increased Cardiovascular Risk in Greece

2018 ◽  
Vol 38 (5) ◽  
pp. 417-426 ◽  
Author(s):  
George Gourzoulidis ◽  
Charalampos Tzanetakos ◽  
Ioannis Ioannidis ◽  
Apostolos Tsapas ◽  
Georgia Kourlaba ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cardiovascular Risk ◽  
Cost Effectiveness

scholarly journals Cost-Effectiveness of Empagliflozin For The Treatment of Patients With Type 2 Diabetes Mellitus At Increased Cardiovascular Risk In Greece

2017 ◽  
Vol 20 (9) ◽  
pp. A479
Author(s):  
G Gourzoulidis ◽  
C Tzanetakos ◽  
I Ioannidis ◽  
A Tsapas ◽  
G Kourlaba ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cardiovascular Risk ◽  
Cost Effectiveness
Sign in / Sign up

Export Citation Format

Share Document